AG

Anirudh Gumansinh Desai

Active Director Director DIN 07397101
DIN 07397101 First appointment Apr 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2016
Shareholding value •••• Premium profile

About Anirudh Gumansinh Desai

Data last updated:

Anirudh Gumansinh Desai is a Director at Necron Pharma Speciality Products Private Limited (since 2016). The company operates in Pharma. Necron Pharma Speciality Products Private Limited reported revenue of ₹3.00 Cr (FY 2024).

DIN 07397101
Primary Designation Director
Industry Pharma
First Appointment 11 Apr 2016
Oldest Company Age 10 yrs
Largest company Necron Pharma Speciality Products Private Limited · ₹3.00 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Apr 20162016₹3.00 Cr (FY 2024)Active

Board colleagues of Anirudh Gumansinh Desai

Directorship timeline

Open interactive timeline →
Necron Pharma Speciality Products Private Limited
Premium access

Shareholding and investment profile for Anirudh Gumansinh Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anirudh Gumansinh Desai

Anirudh Gumansinh Desai currently holds 1 directorship: Necron Pharma Speciality Products Private Limited (Director, since 11 Apr 2016, revenue ₹3.00 Cr (FY 2024)).

Anirudh Gumansinh Desai was first appointed on 11 Apr 2016 as Director at Necron Pharma Speciality Products Private Limited.

The current boards of Anirudh Gumansinh Desai's companies include Karmjeetkumar Dipaksinh Desai (Necron Pharma Speciality Products Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available